期刊文献+

调强放疗技术对骨髓的保护作用 被引量:1

Protective action of bone marrow by intensity-modulated radiotherapy
原文传递
导出
摘要 调强放疗(IMRT)技术应用于肿瘤放疗日益受到关注。骨髓对射线极其敏感,骨髓功能成像技术提高了放疗的精确性,IMRT技术可有目的地减少骨髓受量,降低骨髓的受照射体积,从而有助于降低放疗后急性骨髓抑制的发生概率,值得在临床推广应用。 More and more attention tend to the application of intensity modulated radiation therapy (IMRT) treatment of malignant cancer. The accuracy of the radiotherapy is raising because of the increased radiosensitivity of bone marrow. Imaging modality quantified the distributions of bone marrow, which could further reduce the volume to avoid. Bone marrow-sparing intensity-modulated radiotherapy can reduce the pelvic bone marrow irradiation volume, which may reduce the probability of acute bone marrow inhibit. It is worthy of application widely.
出处 《国际肿瘤学杂志》 CAS 2012年第2期152-154,共3页 Journal of International Oncology
基金 山东省科技发展计划项目(2011GGX10119) 山东省自然科学基金资金项目(ZR2011HM071)
关键词 骨髓 放射疗法 调强适形 Bone marrow Radiotherapy, intensity-modulated
  • 相关文献

参考文献4

二级参考文献19

  • 1胡伟刚,章真,徐志勇,顾卫列,陆惠忠,何少琴.三维适形与调强放疗技术在胃癌术后放疗中的剂量学比较[J].中华放射肿瘤学杂志,2007,16(4):273-276. 被引量:35
  • 2Ahamad A, D' Souza W, Salehpour M, et al. Intensity-modulated radiation therapy afterhysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size ,lnt J Radiat Oncol Biol Phys,2005,62:1117-1124.
  • 3Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys,2002,52:1330-1337.
  • 4Roeske JC, Lujan AE, Reba R, et al. Incorporation of SPECT bone marrow imaging into intensity-modulated whole-pelcie radiation therapy treatment planning for gyncologic malignancies. Radiother Oncol,2005 ,77 :11-17.
  • 5Peters WA, Liu PY, Barrett R J, et al. Conccurent chemotherapy and pelvic radiation therapy compared with pelvic radiation alone as adjuvant therapy after radical surgery in high-risk early stage cancer of cervix. J Clin Oncol,2000,18:1606-1613.
  • 6Mell LK,Kochanski JD, Roeske JC,et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys,2006,66:1356-1365.
  • 7Sedlis A,Bundy BN,Rotman MZ,et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol, 1999,73 : 177-183.
  • 8Mell LK, Tiryaki H, Ahn KH, et al. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus convcntional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys ,2008 ,71:1504-1510.
  • 9Mell LK, Kochanski JD, Roeske JC, et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys ,2006,66 : 1356-1365.
  • 10Mell LK, Schomas DA, Salama JK, et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys, 2008,70 : 1431-1437.

共引文献36

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部